Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2

Conclusion: The ivermectin docking we identified may interfere with the attachment of the spike to the human cell membrane. Clinical trials now underway should determine whether ivermectin is an effective treatment for SARS-Cov2 infection.
Source: In Vivo - Category: Research Authors: Tags: Articles on Covid-19 Source Type: research